The national development in the use of inhaled corticosteroid treatment for chronic obstructive pulmonary disease in Denmark from 1995 to 2018

被引：0
|
作者：
Klitgaard, Allan [1 ]
Ibsen, Rikke [2 ]
Hilberg, Ole [1 ]
Lokke, Anders [1 ]
机构：
[1] Lillebaelt Hosp, Dept Internal Med, Vejle, Denmark
[2] i2minds, Aarhus, Denmark
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
Adults; Treatments; COPD-management;
D O I：
10.1183/13993003.congress-2023.PA4697
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease
    Dave Singh
    Simon Lea
    Alexander G. Mathioudakis
    Drugs, 2021, 81 : 1821 - 1830
  • [32] Evaluation of Inhaled Corticosteroid Efficacy by Electron Microscopy in Patients with Chronic Obstructive Pulmonary Disease
    Tastan, Cagla Pinar
    Erbil, Kadriye Mine
    Okyay, Gulay Ulusal
    Ardic, Sadik
    EURASIAN JOURNAL OF PULMONOLOGY, 2013, 15 (03) : 149 - 154
  • [33] Development of a scoring model for the prediction of the effects of discontinuation or addition of inhaled corticosteroid in chronic obstructive pulmonary disease patients
    Lee, Jang Ho
    Kim, Sehee
    Oh, Yeon-Mok
    RESPIROLOGY, 2023, 28 : 47 - 48
  • [34] Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
    Singh, Dave
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2020, 83 (03) : 185 - 194
  • [35] Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts
    Saito, Zenya
    Yoshida, Masahiro
    Kojima, Ayako
    Tamura, Kentaro
    Hasegawa, Tsukasa
    Kuwano, Kazuyoshi
    LUNG, 2020, 198 (06) : 925 - 931
  • [36] Clusters in chronic obstructive pulmonary disease based on inhaled corticosteroid treatment and pneumonia incidence - a nationwide cohort study
    Klitgaard, Allan
    Ibsen, Rikke
    Hilberg, Ole
    Lokke, Anders
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [37] Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts
    Zenya Saito
    Masahiro Yoshida
    Ayako Kojima
    Kentaro Tamura
    Tsukasa Hasegawa
    Kazuyoshi Kuwano
    Lung, 2020, 198 : 925 - 931
  • [38] How and when to use inhaled corticosteroids in chronic obstructive pulmonary disease?
    Anton, Esther
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (02) : 25 - 32
  • [39] Investigating Prevalence of Eosinophilia and Inhaled Corticosteroid Use in Puerto Rican Patients With Chronic Obstructive Pulmonary Disease: A Retrospective Analysis
    Soto, M.
    Velez-Mojica, K. P.
    Lopez-Ramos, A.
    Aleman-Ortiz, J. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [40] Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
    DiSantostefano, Rachael L.
    Li, Hao
    Rubin, David B.
    Stempel, David A.
    BMJ OPEN, 2013, 3 (04):
12345